'CARTregs have been developed to induce and maintain immunological tolerance in patients with renal and liver transplant rejection and are also being developed for use in the autoimmune diseases refractory rheumatoid arthritis and hidradenitis suppurativa. Clinical trials are still in early stages.'

How do we make CAR Tregs? Take a peek behind the curtain of the Ferreira Lab at the Medical University of South Carolina and MUSC Hollings Cancer Center!
#immunologymatters #changingwhatspossible #CARTregs

app.jove.com/v/67200/gene...